Editors

Human Psychopharmacology: Experimental

For North and South America
Principal editor
Amy Janes, PhD, National Institute on Drug Abuse (NIDA), National Institutes of Health (NIH)*, United States
Advisory editors
Robin Carhart-Harris, PhD, San Francisco, United States
Margaret Haney, PhD, Columbia University Medical Center, United States
Marco Leyton, PhD, McGill University, Canada
Edythe D London, PhD, University of California, Los Angeles, United States
Sarah Yip, PhD, Yale Scshool of Medicine, United States

For the rest of the world
Principal editor
Mitul A. Mehta, PhD, King's College London, United Kingdom
Advisory editors
Benjamin Becker, PhD, The University of Hong Kong, China
Gillinder Bedi, PhD, Orygen, The National Centre of Excellence, Australia
R. Cools, PhD, Radboud University Nijmegen, The Netherlands

Human Psychopharmacology: Clinical and Translational

For North and South America
Principal editor

Deepak Cyril D'Souza, MD, Yale University School of Medicine, United States
Advisory editors
Chadi G Abdallah, MD, Yale University School of Medicine, United States
Anissa Abi-Dargham, MD, Stony Brook University, United States
Sanjay J Mathew, MD, Baylor College of Medicine, United States
Christopher J McDougle, MD, Massachusetts General Hospital, Harvard Medical School, United States

For the rest of the world
Principal editor
James Stone, MBBS, PhD, University of Sussex, United Kingdom
Advisory editors
Eric Y. H. Chen, PhD, University of Hong Kong, China
Dan Siskind, MBBS, MPH, PhD, FRANZCP, Faculty of Medicine, University of Queensland, Australia
Hiroyuki Uchida, MD, PhD, Department of Neuropsychiatry, Keio University School of Medicine, Japan

Preclinical Psychopharmacology: Behavioral and Neural

For North and South America
Principal editor
Patricia Janak, PhD, Johns Hopkins University, USA
Advisory editors
Susan L. Andersen, PhD, Boston Children's Hospital, United States
Francisco S Guimarães, MD, PhD, Institution Department of Pharmacology, Medical School of Ribeirao Preto, University of São Paulo, Brazil
J David Jentsch, PhD, Binghamton University, United States
Emily M Jutkiewicz, PhD, University of Michigan Medical School, United States
Tamara J Phillips, PhD, Oregon Health & Science University, United States
Marina R Picciotto, PhD, Yale School of Medicine, United States
Yavin Shaham, PhD, National Institute on Drug Abuse (NIDA), National Institutes of Health (NIH)*, United States

For the rest of the world
Principal editor
Trevor Robbins, CBE, FRS, FMedSci, PhD, University of Cambridge, United Kingdom
Advisory editors
David Belin, PhD, HDR , Professor of Behavioural Neuroscience, University of Cambridge, United Kingdom
Bart A Ellenbroek, PhD, Victoria University of Wellington, New Zealand
Christian P Müller, PhD, MD, Department of Psychiatry and Psychotherapy, Friedrich-Alexander-University of Erlangen-Nuremberg, Germany
Joanna C Neill, PhD, The University of Manchester, United Kingdom
Emma Robinson, PhD, University of Bristol, United Kingdom
Louk J.M.J. Vanderschuren, , Utrecht University,

Preclinical Psychopharmacology: Translational

For North and South America
Principal editor
Stan Floresco, PhD, University of British Columbia, Canada
Advisory editors
Andrew Holmes, PhD, National Institute on Alcohol Abuse and Alcoholism, United States
Janet L. Neisewander, PhD, Arizona State University, United States
Neal R. Swerdlow, MD, PhD, University of California, United States
S.V. Mahler, PhD, University of California, Irvine, United States

For the rest of the world
Principal editor

Christelle Baunez, PhD, Institute of Neurosciences Timone, Aix-Marseille University, France
Advisory editors
Aldo Badiani, PhD, Sapienza Università di Roma, Italy
Anton Bespalov, MD, DMedSci, EXCIVA, Germany
Mickaël Naassila, PhD, The University of Picardy Jules Verne, France

Preclinical Psychopharmacology: Molecular, Genetic and Epigenetic

For North and South America
Principal editor
Debra Bangasser, PhD, Georgia State University, USA
Advisory editors
Jacqueline F. McGinty, PhD, MUSC Brain Research Institute, Medical University of South Carolina, United States
Donita Lynn Robinson, PhD, University of North Carolina at Chapel Hill School of Medicine, United States
Bryan L Roth, MD, PhD, UNC Chapel Hill School of Medine, United States
William Carlezon, PhD, Harvard Brain Science Institute, United States

For the rest of the world
Principal editor
Kenji Hashimoto, PhD, Chiba University, Japan
Advisory editors
Shigeyuki Chaki, PhD, Fellow, Research Headquarters, Taisho Pharmaceutical Co., Ltd., Japan
John F Cryan, PhD, University College Cork, Ireland
Andrew J Lawrence, HonFBPhS, Florey Institute of Neuroscience & Mental Health, Australia
Marie-Christine Pardon, PhD, University of Nottingham, United Kingdom
Marco Andrea Riva, PhD, University of Milan, Italy
Wenhua Zhou, PhD, Ningbo University, China

Social Media Editor
S.V. Mahler, PhD, University of California, Irvine, United States
 

*Dr. Amy Janes is serving in her personal capacity.
*Dr. Yavin Shaham is serving in his personal capacity